Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

1141248

registered interest
date	23/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Loneliness: Social Prescribing
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress his Department has made on the commitment made in the loneliness strategy to launch an online social prescribing platform for commissioners and practitioners.
tabling member constituency	Worsley and Eccles South
tabling member printed	Barbara Keeley
uin	280961
answer	answer is ministerial correction date of answer 03/09/2019 answer text <p>NHS England has launched the online social prescribing platform for commissioners and practitioners which includes templates, resources and facilitates regional communities of practice. Further information can be found at the following link:</p><p><a href="https://www.england.nhs.uk/personalisedcare/social-prescribing/" target="_blank">https://www.england.nhs.uk/personalisedcare/social-prescribing/</a></p><p> </p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 03/09/2019 16:27:23 answering member 4380 label Biography information for Jo Churchill
tabling member	1588 label Biography information for Barbara Keeley

1141249

registered interest
date	23/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Loneliness: Social Prescribing
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what progress his Department has made on the commitment made in the loneliness strategy to pilot accredited learning programmes for social prescribing link workers.
tabling member constituency	Worsley and Eccles South
tabling member printed	Barbara Keeley
uin	280962
answer	answer is ministerial correction date of answer 03/09/2019 answer text <p>Accredited learning programmes for social prescribing link workers have been developed and are now being delivered by Connexus Healthcare. Further information can be found at the following link:</p><p><a href="https://conexus-healthcare.org/social-prescribing-qualification-training/" target="_blank">https://conexus-healthcare.org/social-prescribing-qualification-training/</a></p><p>After a successful six-month pilot course – the only one of its kind in the United Kingdom – Connexus and its partners have trained the country’s very first group of qualified social prescribers. Plans are now underway to unveil the next cohort of social prescribing courses and qualifications in autumn 2019.</p><p> </p><p> </p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 03/09/2019 16:21:57 answering member 4380 label Biography information for Jo Churchill
tabling member	1588 label Biography information for Barbara Keeley

1141251

registered interest
date	23/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Cancer: Health Services
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, when a long-term workforce plan which sets out the number of staff required to meet the current and future needs of cancer patients will be published.
tabling member constituency	Denton and Reddish
tabling member printed	Andrew Gwynne
uin	280964
answer	answer is ministerial correction date of answer 05/08/2019 answer text <p>The interim NHS People Plan, published on 3 June 2019, puts the workforce at the heart of the National Health Service and will ensure we have the staff needed to deliver high quality care. A final People Plan will be published soon after the conclusion of the 2019 Spending Review.</p><p>Phase 1 of the Cancer Workforce Plan for England, published in December 2017 by Health Education England (HEE), set out plans to expand capacity and skills in the cancer workforce, including targeting additional training support for seven priority professions which are key to cancer prevention, diagnosis and treatment, such as clinical radiology, histopathology, oncology and diagnostic and therapeutic radiography.</p><p>HEE will now work with NHS England and NHS Improvement to understand the longer-term workforce implications of further development of cancer services. This work will inform the final People Plan.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill question first answered 05/08/2019 11:30:43 answering member 4380 label Biography information for Jo Churchill
tabling member	1506 label Biography information for Andrew Gwynne

1141253

registered interest
date	23/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	NHS: Drugs
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what recent assessment he has made of the potential effect of the UK leaving the EU on the supply of drugs to the NHS.
tabling member constituency	Tooting
tabling member printed	Dr Rosena Allin-Khan
uin	281022
answer	answer is ministerial correction date of answer 02/08/2019 answer text <p>The United Kingdom will leave the European Union on 31 October, with or without a deal. The Government would prefer the UK to leave the EU with a deal and, in the event that the UK leaves the EU with a new deal, the Department’s assessment is that access to medicines and medical devices will not change for industry or the National Health Service.</p><p>While the Prime Minister is confident that he can strike a new arrangement with the EU, it is vital that we prepare for a ‘no deal’ outcome. Therefore, as a responsible Government, we continue to take steps to ensure the supply of medicines and medical products is uninterrupted in a ‘no deal’ scenario.</p><p>On 26 June, we wrote to suppliers of medicines to the UK from or via the EU or European Economic Area setting out our continuing multi-layered approach to ensure the continuity of supply of all medicines and medical products in a potential ‘no deal’ exit scenario on 31 October.</p><p>Further details can be found at the following link:</p><p><a href="https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans" target="_blank">https://www.gov.uk/government/news/medicines-and-medical-products-supply-government-updates-no-deal-brexit-plans</a></p><p>Ahead of 31 October, all necessary funding will be made available to support our ‘no deal’ preparations. On 1 August, Her Majesty’s Treasury announced an additional £434 million made available to help ensure continuity of supply of vital medicines and medical products, including through freight capacity, warehousing and stockpiling.</p><p>We are confident that the Department is doing everything appropriate to prepare for a possible ‘no deal’ EU exit on 31 October. We are working with our partners, including suppliers, freight companies and the health and social care system and our plans should ensure the supply of medicines and medical products remains uninterrupted.</p> answering member constituency Kingswood answering member printed Chris Skidmore question first answered 02/08/2019 09:59:35 answering member 4021 label Biography information for Chris Skidmore
tabling member	4573 label Biography information for Dr Rosena Allin-Khan

1141255

registered interest
date	23/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Non-surgical Cosmetic Procedures: Children
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what legal duties govern the administering of dermal fillers to people under the age of 18 by non-regulated practitioners.
tabling member constituency	North Durham
tabling member printed	Mr Kevan Jones
uin	280927
answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>Currently there are no restrictions that limit the administration of dermal fillers on young people under the age of 18 years old.</p><p>The Department is exploring options to introduce age restrictions on access to cosmetic procedures, bringing them in line with legislation on tattoos, teeth whitening and the use of sunbeds. From May 2020 all dermal fillers, irrespective of their composition and intended use, will be regulated as medical devices under Annex XVI of the Medical Device Regulations (EU 2017/745). The new Regulations will significantly improve the quality and safety of dermal fillers.</p><p>The Government is committed to improving the safety of cosmetic procedures through better training for practitioners, and clear information so that people can make informed decisions about their care. The growth in non-surgical treatments increases the need for consumer protection and we are currently working with stakeholders to strengthen the regulation of cosmetic procedures.</p><p>We urge anyone seeking a cosmetic procedure to take the time to find a reputable, insured and appropriately qualified practitioner who is either subject to statutory regulation or on a voluntary register accredited by the Professional Standards Authority.</p> answering member constituency Thurrock answering member printed Jackie Doyle-Price question first answered 25/07/2019 16:32:36 answering member 4065 label Biography information for Dame Jackie Doyle-Price
tabling member	1438 label Biography information for Mr Kevan Jones

1141269

registered interest
date	23/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Essential Tremor: Ultrasonics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what representations his Department has received following recommendations from NICE on NHS England adopting a commissioning policy for MR-guided focused ultrasound for essential tremor; and if he will make a statement.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	280966
answer	answer is ministerial correction date of answer 03/09/2019 answer text <p>In June 2018, the National Institute for Heath and Care Excellence (NICE) developed interventional procedure guidance on ‘Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor’. NICE’s interventional procedures guidance looks at whether procedures are safe enough and work well enough for wider use in the National Health Service.</p><p>Due to limited evidence on efficacy, NICE’s guidance recommends that this procedure should not be used unless there are special arrangements for clinical governance, consent and audit or research.</p><p>A search of the Department’s Ministerial correspondence database from 1 January 2017 to 25 July 2019 has identified four items of correspondence received on the MR-guided focused ultrasound for essential tremor. This figure represents correspondence received by the Department’s Ministerial correspondence unit only.</p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 03/09/2019 11:47:36 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1604 label Biography information for Mr Virendra Sharma

1141270

registered interest
date	23/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Essential Tremor: Ultrasonics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment has been made by his Department's agencies and public bodies of the potential clinical benefits of MR-guided focused ultrasound as a treatment for essential tremor; and if he will make a statement.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	280967
answer	answer is ministerial correction date of answer 03/09/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) has reviewed Magnetic Resonance Imaging-guided focused ultrasound (MRgFUS) as a treatment for essential tremor and published Interventional Procedure (IP) guidance on this treatment in June 2018. This concluded that the evidence on the safety of unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor raises no major safety concerns. However, current evidence on its efficacy is limited in quantity. Therefore, this procedure should not be used unless there are special arrangements for clinical governance, consent, and audit or research.</p><p> </p><p>NHS England is in the early stages of developing a national clinical commissioning policy for MRgFUS for essential tremor. The policy will determine whether or not the intervention will or be routinely commissioned and include criteria to guide clinical decision-making about the patients who may be able to benefit.</p><p> </p><p>The development of a national clinical policy by NHS England is complex. This takes time, including proper consideration of the evidence and involvement of clinical experts. To ensure consistency and fairness, NHS England follows a standard three stage process. Full details can be found on the NHS England website at the following link:</p><p> </p><p><a href="http://www.england.nhs.uk/publication/methods-national-clinical-policies/" target="_blank">www.england.nhs.uk/publication/methods-national-clinical-policies/</a></p><p> </p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 280968 280969 280970 question first answered 03/09/2019 11:39:45 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1604 label Biography information for Mr Virendra Sharma

1141271

registered interest
date	23/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Essential Tremor: Ultrasonics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what assessment has been made by his Department's agencies and public bodies of the potential value for money of MR-guided focused ultrasound as a treatment for essential tremor; and if he will make a statement.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	280968
answer	answer is ministerial correction date of answer 03/09/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) has reviewed Magnetic Resonance Imaging-guided focused ultrasound (MRgFUS) as a treatment for essential tremor and published Interventional Procedure (IP) guidance on this treatment in June 2018. This concluded that the evidence on the safety of unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor raises no major safety concerns. However, current evidence on its efficacy is limited in quantity. Therefore, this procedure should not be used unless there are special arrangements for clinical governance, consent, and audit or research.</p><p> </p><p>NHS England is in the early stages of developing a national clinical commissioning policy for MRgFUS for essential tremor. The policy will determine whether or not the intervention will or be routinely commissioned and include criteria to guide clinical decision-making about the patients who may be able to benefit.</p><p> </p><p>The development of a national clinical policy by NHS England is complex. This takes time, including proper consideration of the evidence and involvement of clinical experts. To ensure consistency and fairness, NHS England follows a standard three stage process. Full details can be found on the NHS England website at the following link:</p><p> </p><p><a href="http://www.england.nhs.uk/publication/methods-national-clinical-policies/" target="_blank">www.england.nhs.uk/publication/methods-national-clinical-policies/</a></p><p> </p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 280967 280969 280970 question first answered 03/09/2019 11:39:45 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1604 label Biography information for Mr Virendra Sharma

1141273

registered interest
date	23/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Essential Tremor: Ultrasonics
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if his Department will provide interim funding for NHS patients to access MR-guided focused ultrasound as a treatment for essential tremor at St Mary’s Hospital, Imperial College Healthcare Trust; and if he will make a statement.
tabling member constituency	Ealing, Southall
tabling member printed	Mr Virendra Sharma
uin	280970
answer	answer is ministerial correction date of answer 03/09/2019 answer text <p>The National Institute for Health and Care Excellence (NICE) has reviewed Magnetic Resonance Imaging-guided focused ultrasound (MRgFUS) as a treatment for essential tremor and published Interventional Procedure (IP) guidance on this treatment in June 2018. This concluded that the evidence on the safety of unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor raises no major safety concerns. However, current evidence on its efficacy is limited in quantity. Therefore, this procedure should not be used unless there are special arrangements for clinical governance, consent, and audit or research.</p><p> </p><p>NHS England is in the early stages of developing a national clinical commissioning policy for MRgFUS for essential tremor. The policy will determine whether or not the intervention will or be routinely commissioned and include criteria to guide clinical decision-making about the patients who may be able to benefit.</p><p> </p><p>The development of a national clinical policy by NHS England is complex. This takes time, including proper consideration of the evidence and involvement of clinical experts. To ensure consistency and fairness, NHS England follows a standard three stage process. Full details can be found on the NHS England website at the following link:</p><p> </p><p><a href="http://www.england.nhs.uk/publication/methods-national-clinical-policies/" target="_blank">www.england.nhs.uk/publication/methods-national-clinical-policies/</a></p><p> </p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 280967 280968 280969 question first answered 03/09/2019 11:39:45 answering member 4008 label Biography information for Dame Caroline Dinenage
tabling member	1604 label Biography information for Mr Virendra Sharma

1141283

registered interest
date	23/07/2019
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Electronic Cigarettes
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, if he will bring forward legislative proposals to ban e-cigarettes wherever the smoking ban is in place. .
tabling member constituency	North East Hampshire
tabling member printed	Mr Ranil Jayawardena
uin	281031
answer	answer is ministerial correction date of answer 05/08/2019 answer text <p>The Government believes in proportionate regulation of e-cigarettes, recognising that they are not risk-free. Through the European Union Tobacco Products Directive 2014/40/EU (TPD), transposed into United Kingdom law by the UK Tobacco and Related Products Regulations 2016 (TRPR), we have introduced measures to regulate e-cigarettes. These measures reduce the risk of harm to children, protect against any risk of renormalisation of tobacco use, provide assurance on relative safety for users, and give businesses legal certainty. This has enabled the UK to implement appropriate standards for products whilst allowing smokers to move to e-cigarettes should they wish.</p><p> </p><p>The Government has made a commitment to review the TRPR by May 2021 to consider its regulatory impact. In addition, as announced in the Tobacco Control Plan the Government will review where the UK’s exit from the European Union offers us opportunities to re-appraise current regulation to ensure this continues to protect the nation’s health.</p><p>The Government has no plans to introduce legislative proposals to ban e-cigarettes, e-cigarette shops or smoking on National Health Service property.</p><p>We continue to support the implementation of smokefree policies across all hospitals in England. The Government’s tobacco control plan for England published in July 2017 reiterates our ambition to achieve smokefree mental health services and NHS estate by 2019/20. The NHS Long Term Plan, published in January 2019, further supports the creation of a Smokefree NHS with the commitment to offering NHS-funded tobacco treatment services to all patients who smoke.</p> answering member constituency Bury St Edmunds answering member printed Jo Churchill grouped question UIN 281032 question first answered 05/08/2019 11:29:19 answering member 4380 label Biography information for Jo Churchill
tabling member	4498 label Biography information for Mr Ranil Jayawardena